期刊
JOURNAL OF CHILD NEUROLOGY
卷 23, 期 12, 页码 1377-1381出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0883073808318547
关键词
topiramate; sodium valproate; migraine; Pediatric Migraine Disability Assessment
Frequent migraine headaches can have a significant impact on disability, prompting the need for early recognition and treatment. The objective Of this Study is to compare the efficacy of topiramate and Sodium Valproate for the prevention of pediatric migraine, retrospectively. Mean monthly migraine frequency, intensity, and duration in the 28 patients treated with topiramate decreased from 15.3 +/- 10.1 to 4.4 +/- 5.5 episode, from 6.8 +/- 1 to 3.2 1, and from 10.2 +/- 9.4 to 2.4 +/- 3.1 hours, respectively Headache disability improved with a reduction of Pediatric Migraine Disability Assessment score from 36 +/- 29.5 to 4.6 +/- 6.5 (P < .05). Similarly, mean monthly headache frequency, headache intensity, headache duration, and Pediatric Migraine Disability Assessment score in the 20 patients treated with sodium valproate decreased from 20.1 +/- 10.2 to 6.6 +/- 8.6, from 7.1 +/- 1 to 3.4 +/- 2.1, from 7 +/- 12 to 1.4 +/- 2.5 hours, and from 20.5 +/- 16.1 to 5.5 +/- 9.2, respectively (P < .05). In conclusion, valproate and topiramate seem to be able to manage successfully childhood migraine without substantial differences in efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据